Isotopia Molecular Imaging and CPDC are pleased to announce that they have entered into an agreement for the production and distribution of no-carrier-added Lutetium-177 (n.c.a. Lu-177), a critical medical radioisotope used in the manufacturing of radiopharmaceuticals for treatment of many types of cancer, including neuroendocrine tumors and prostate cancer. The Centre for Probe Development and […]
READ MORE
All across Canada, provincial leaders in the Health, Energy, Natural Resources and Research and Innovation portfolios are receiving an information package today from the Canadian Nuclear Isotope Council (CNIC) as it continues to push for a Pan-Canadian Strategy on isotopes.
READ MORE
On behalf of the Canadian Nuclear Isotope Council (CNIC), we would like to provide this submission to the Standing Committee on Finance & Economic Affairs regarding the government’s consultation on Bill 188, the Economic and Fiscal Update.
READ MORE
The Nuclear Innovation Institute (NII) and Canadian Nuclear Isotope Council (CNIC) have partnered on an innovative study to identify challenges and evaluate potential technology, logistical, regulatory and policy solutions in Canada’s medical isotope supply chain.
READ MORE
Stevcon Packaging & Logistics LTD (SP&L) located in Owen Sounds and a leading designer and producer of packaging to Tier 1, 2 and 3 suppliers for both domestic and global nuclear projects is now part of the Canadian Nuclear Isotope Council (CNIC).
READ MORE
